Log In
Print
BCIQ
Print
Print this Print this
 

ISF35

  Manage Alerts
Collapse Summary General Information
Company Memgen LLC
DescriptionImmunostimulatory CD40 binding protein
Molecular Target CD40
Mechanism of ActionVaccine
Latest Stage of DevelopmentPhase II
IndicationChronic lymphocytic leukemia (CLL)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today